The bio-tech industry giant, Textron Inc. (TXT) have been creating waves in the market. Their Q4 earnings surpassed estimates and revenues showed a hike Year over Year (YoY) which has earned them a position in various portfolios, including that of Cibc World Markets Corp, Vinva Investment Management Ltd, Jones Financial Companies Lllp, NEOS Investment Management LLC, and Bank of Nova Scotia. TXT continues to innovate with enhanced features for Cessna Citation Jets, is seen as a strong growth stock for the long-term, and wins contracts to aid T-6C training aircraft.
This success comes with a downside, as it also resulted in multiple sales of their stock by CIBC Asset Management Inc, Gabelli Funds LLC, and Orion Portfolio Solutions LLC amongst others. This fluctuating trend has seen TXT stock lose around -11.5% in 4 weeks but it might expect a reversal. Zacks research have lifted their EPS estimates for Q1 & Q2 2025. However, some believe there is caution warranted over Textron's increasing CEO pay. Despite recent losses, the company continues to thrive and quarterly dividends have been declared.
Notwithstanding, TXT is still considered a strong value stock in the long-term, with a bullish forecast as they continue to outpace their aerospace peers. There have been good investment returns to those who betted on TXT five years ago.
Textron TXT News Analytics from Wed, 06 Dec 2023 08:00:00 GMT to Sun, 09 Jun 2024 18:01:54 GMT - Rating 5 - Innovation 8 - Information 8 - Rumor -2
